ESC 365 - Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.

ESC Premium Access

Clopidorel-based antiplatelet therapy is not enough for stent patency in patients undergoing femoropopliteal arterial endovascular interventions.

Session: Poster Session 4 - Peripheral artery disease : endovascular treatment

Topic: Peripheral Angiography

Speaker: Doctor K. Higashi (Kagoshima, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Kensaku Higashi

National Hospital Organization Kagoshima Medical Center, Kagoshima (Japan)

0 follower

9 more presentations in this session

Outcome of spot versus full-coverage nitinol stenting after endovascular therapy for femoropopliteal artery disease

Speaker: Doctor Y. Tomoi (Kitakyushu, JP)

Impact of baseline characteristics on efficacy of cilostazol for patients performing endovascular therapy for femoropopliteal lesions

Speaker: Doctor S. Hiramori (Kitakyushu, JP)

Long term usefulness of target lesion revascularization for asymptomatic restenosis of superficial femoral artery after endovascular therapy

Speaker: Doctor M. Utsunomiya (Tokyo, JP)

Comparison of transradial vs transfemoral access for iliac, femoral, and popliteal interventions. A single-center experience

Speaker: Associate Professor Z. Ruzsa (Szeged, HU)

Predictive value of vessel size for the long-term patency following self-expanding nitinol stent implantation in the superficial femoral artery

Speaker: Doctor K. Miki (Nishinomiya, JP)

Access the full session

Poster Session 4 - Peripheral artery disease : endovascular treatment

Speakers: Doctor K. Higashi, Doctor Y. Tomoi, Doctor S. Hiramori, Doctor M. Utsunomiya, Associate Professor Z. Ruzsa...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources